Financhill
Buy
56

AFYA Quote, Financials, Valuation and Earnings

Last price:
$15.19
Seasonality move :
-4.23%
Day range:
$15.15 - $15.27
52-week range:
$13.47 - $19.90
Dividend yield:
1.53%
P/E ratio:
11.08x
P/S ratio:
2.20x
P/B ratio:
1.54x
Volume:
43.7K
Avg. volume:
101K
1-year change:
-4.89%
Market cap:
$1.4B
Revenue:
$612.9M
EPS (TTM):
$1.37

Analysts' Opinion

  • Consensus Rating
    Afya Ltd. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 2 Hold ratings, and 2 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $19.25, Afya Ltd. has an estimated upside of 26.82% from its current price of $15.18.
  • Price Target Downside
    According to analysts, the lowest downside price target is $15.89 representing 100% downside risk from its current price of $15.18.

Fair Value

  • According to the consensus of 6 analysts, Afya Ltd. has 26.82% upside to fair value with a price target of $19.25 per share.

AFYA vs. S&P 500

  • Over the past 5 trading days, Afya Ltd. has overperformed the S&P 500 by 2.98% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Afya Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Afya Ltd. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Afya Ltd. reported revenues of $170.4M.

Earnings Growth

  • Afya Ltd. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Afya Ltd. reported earnings per share of $0.31.
Enterprise value:
1.8B
EV / Invested capital:
1.20x
Price / LTM sales:
2.20x
EV / EBIT:
8.36x
EV / Revenue:
2.75x
PEG ratio (5yr expected):
0.85x
EV / Free cash flow:
12.60x
Price / Operating cash flow:
10.10x
Enterprise value / EBITDA:
6.40x
Gross Profit (TTM):
$414.4M
Return On Assets:
8.14%
Net Income Margin (TTM):
20.49%
Return On Equity:
16.42%
Return On Invested Capital:
9.65%
Operating Margin:
30.62%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $540M $616.7M $638.2M $151.7M $170.4M
Gross Profit $330.8M $385M $414.4M $93.2M $108M
Operating Income $144.4M $179.8M $210M $42.8M $52.2M
EBITDA $197.3M $243M $274.2M $58.2M $69.6M
Diluted EPS $0.77 $1.21 $1.37 $0.24 $0.31
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $263.1M $224.4M $284.2M $271.1M $330.9M
Total Assets $1.2B $1.2B $1.6B $1.6B $1.7B
Current Liabilities $121M $180.6M $241.1M $169.9M $338M
Total Liabilities $630M $663.2M $855.5M $837.7M $826.3M
Total Equity $560.5M $586.8M $709.1M $762.4M $898.8M
Total Debt $390.3M $364.4M $517.7M $567.4M $386.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $210.1M $200M $197.8M $79M $77.4M
Cash From Investing -$220M -$216.2M -$88M -$109M -$27.7M
Cash From Financing $26.4M $15.3M -$83.6M $50M -$67M
Free Cash Flow $157.5M $125.1M $139.3M $48.2M $61.7M
AFYA
Sector
Market Cap
$1.4B
$327.7M
Price % of 52-Week High
76.28%
73.46%
Dividend Yield
1.53%
0%
Shareholder Yield
-1.23%
2.01%
1-Year Price Total Return
-4.89%
-6.61%
Beta (5-Year)
0.516
0.547
Dividend yield:
1.53%
Annualized payout:
$0.00
Payout ratio:
-19.72%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $15.00
200-day SMA
Sell
Level $16.42
Bollinger Bands (100)
Buy
Level 14.4 - 15.48
Chaikin Money Flow
Buy
Level 2.5M
20-day SMA
Buy
Level $14.69
Relative Strength Index (RSI14)
Buy
Level 60.12
ADX Line
Buy
Level 17.33
Williams %R
Sell
Level -9.375
50-day SMA
Buy
Level $14.85
MACD (12, 26)
Buy
Level 0.12
25-day Aroon Oscillator
Buy
Level 28
On Balance Volume
Neutral
Level 9.2M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.4361)
Buy
CA Score (Annual)
Level (0.1884)
Buy
Beneish M-Score (Annual)
Level (-2.9419)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.2537)
Buy
Piotroski F Score (Annual)
Level (9)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences, and other undergraduate programs. The Residency Preparatory and Specialization Programs segment offers digital and printed medical content services, including online courses for residency preparatory, medical and other than medical post-graduate specialization programs and mobile app subscription for digital medical content. The company was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.

Stock Forecast FAQ

In the current month, AFYA has received 2 Buy ratings 2 Hold ratings, and 2 Sell ratings. The AFYA average analyst price target in the past 3 months is $19.25.

  • Where Will Afya Ltd. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Afya Ltd. share price will rise to $19.25 per share over the next 12 months.

  • What Do Analysts Say About Afya Ltd.?

    Analysts are divided on their view about Afya Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Afya Ltd. is a Sell and believe this share price will drop from its current level to $15.89.

  • What Is Afya Ltd.'s Price Target?

    The price target for Afya Ltd. over the next 1-year time period is forecast to be $19.25 according to 6 Wall Street analysts, 2 of them rate the stock a Buy, 2 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is AFYA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Afya Ltd. is a Hold. 2 of 6 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of AFYA?

    You can purchase shares of Afya Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Afya Ltd. shares.

  • What Is The Afya Ltd. Share Price Today?

    Afya Ltd. was last trading at $15.19 per share. This represents the most recent stock quote for Afya Ltd.. Yesterday, Afya Ltd. closed at $15.18 per share.

  • How To Buy Afya Ltd. Stock Online?

    In order to purchase Afya Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock